Moreno - Summary Research Study 2
Moreno - Summary Research Study 2
The study focuses on Retinitis Pigmentosa (RP), a degenerative eye condition that
blinds or seriously compromises vision. RP causes the retina to lose its response to
light, which causes a gradual vision loss. RP patients usually have a slow decrease in
their peripheral perception, night vision, and finally their central vision, therefore
compromising their quality of life.
The research looks into the Argus II Retinal Prosthesis System, also referred to as the
"bionic eye," to fight this crippling disorder. The Argus II device is meant to help those
with severe to profound RP somewhat regain vision. It entails surgically implanting a
tiny electrical device on the retina's surface. This gadget runs in concert with a set of
spectacles with a tiny video camera. The camera records visual data and wirelessly
sends it to the device, which subsequently activates the cells of the retina to produce
visual impressions in the brain.
The study's findings clearly reveal that for those with RP, the Argus II system greatly
enhances visual capacity. Argus II users have claimed to be able to see light,
differentiate big objects, and maybe detect motion. Their standard of life is much
improved by this partial return of eyesight as it enables them to accomplish simple
chores and negotiate their surroundings more freely.
Long-term safety and performance of the Argus II system have been shown by clinical
trials. Patients' visual function improved steadily over three years without any apparent
side effects. These results highlight the transforming power of the Argus II technology in
providing a workable answer for advanced RP sufferers.